William Renthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleus Accumbens | 13 | 2023 | 362 | 1.700 |
Why?
|
| Migraine Disorders | 6 | 2022 | 1595 | 1.410 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 4 | 2023 | 192 | 1.000 |
Why?
|
| Peripheral Nervous System | 3 | 2022 | 140 | 0.890 |
Why?
|
| Rett Syndrome | 3 | 2023 | 163 | 0.840 |
Why?
|
| Trigeminal Ganglion | 1 | 2022 | 186 | 0.800 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 26 | 0.770 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2020 | 53 | 0.750 |
Why?
|
| Cocaine | 11 | 2013 | 1003 | 0.630 |
Why?
|
| Ganglia, Spinal | 1 | 2020 | 525 | 0.630 |
Why?
|
| Epigenomics | 1 | 2023 | 855 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-fos | 9 | 2010 | 577 | 0.620 |
Why?
|
| Sensory Receptor Cells | 2 | 2022 | 460 | 0.590 |
Why?
|
| Chromatin | 9 | 2023 | 2849 | 0.580 |
Why?
|
| Gene Expression Regulation | 12 | 2020 | 12180 | 0.580 |
Why?
|
| Epigenesis, Genetic | 8 | 2017 | 3596 | 0.570 |
Why?
|
| Internal Capsule | 1 | 2016 | 113 | 0.540 |
Why?
|
| Neuralgia | 1 | 2020 | 522 | 0.500 |
Why?
|
| Wernicke Encephalopathy | 1 | 2014 | 29 | 0.490 |
Why?
|
| Thiamine Deficiency | 1 | 2014 | 39 | 0.480 |
Why?
|
| Central Nervous System | 1 | 2019 | 1301 | 0.430 |
Why?
|
| Dopamine Uptake Inhibitors | 7 | 2013 | 311 | 0.400 |
Why?
|
| Cocaine-Related Disorders | 4 | 2013 | 457 | 0.370 |
Why?
|
| Thalamus | 1 | 2016 | 1016 | 0.370 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1404 | 0.350 |
Why?
|
| RNA | 2 | 2019 | 2718 | 0.340 |
Why?
|
| Substance-Related Disorders | 4 | 2009 | 4187 | 0.330 |
Why?
|
| Brain | 12 | 2023 | 25764 | 0.330 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 701 | 0.330 |
Why?
|
| Histone Deacetylases | 5 | 2009 | 749 | 0.320 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1620 | 0.310 |
Why?
|
| Histones | 9 | 2010 | 2559 | 0.310 |
Why?
|
| Amphetamine | 1 | 2008 | 219 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17354 | 0.300 |
Why?
|
| Neuronal Plasticity | 5 | 2020 | 1402 | 0.290 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1624 | 0.290 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 2001 | 0.280 |
Why?
|
| Sirtuins | 1 | 2009 | 370 | 0.270 |
Why?
|
| Anorexia Nervosa | 1 | 2014 | 1271 | 0.260 |
Why?
|
| Neurons | 14 | 2023 | 9344 | 0.260 |
Why?
|
| Genomics | 1 | 2020 | 5565 | 0.250 |
Why?
|
| Behavior, Animal | 9 | 2010 | 1888 | 0.250 |
Why?
|
| Mice | 26 | 2023 | 80300 | 0.240 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9379 | 0.240 |
Why?
|
| Reward | 6 | 2013 | 923 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2018 | 6539 | 0.220 |
Why?
|
| DNA Methylation | 6 | 2019 | 4311 | 0.210 |
Why?
|
| Animals | 35 | 2023 | 168714 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9245 | 0.210 |
Why?
|
| Stress, Psychological | 6 | 2010 | 4160 | 0.210 |
Why?
|
| Pain | 1 | 2016 | 4830 | 0.200 |
Why?
|
| Axotomy | 1 | 2020 | 75 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2016 | 3545 | 0.190 |
Why?
|
| Spinal Nerves | 1 | 2020 | 87 | 0.190 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 364 | 0.180 |
Why?
|
| Dendritic Spines | 3 | 2010 | 233 | 0.180 |
Why?
|
| Mechanoreceptors | 1 | 2020 | 182 | 0.170 |
Why?
|
| Analgesia | 1 | 2023 | 470 | 0.170 |
Why?
|
| Acetylation | 4 | 2009 | 1112 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2008 | 626 | 0.160 |
Why?
|
| Depression | 8 | 2010 | 7454 | 0.150 |
Why?
|
| Headache | 2 | 2022 | 1162 | 0.150 |
Why?
|
| Sciatic Nerve | 1 | 2020 | 605 | 0.150 |
Why?
|
| Neuroglia | 1 | 2022 | 922 | 0.150 |
Why?
|
| Nociceptors | 1 | 2020 | 436 | 0.150 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2007 | 597 | 0.140 |
Why?
|
| Disease Models, Animal | 8 | 2023 | 18033 | 0.140 |
Why?
|
| Mosaicism | 1 | 2018 | 442 | 0.140 |
Why?
|
| Hypesthesia | 1 | 2016 | 106 | 0.140 |
Why?
|
| Constipation | 1 | 2020 | 517 | 0.140 |
Why?
|
| Placebos | 1 | 2020 | 1691 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 16 | 2013 | 22134 | 0.130 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 803 | 0.130 |
Why?
|
| Imipramine | 3 | 2009 | 99 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2019 | 3042 | 0.120 |
Why?
|
| Morphine Dependence | 1 | 2013 | 28 | 0.120 |
Why?
|
| Nervous System | 2 | 2008 | 560 | 0.120 |
Why?
|
| PC12 Cells | 3 | 2009 | 334 | 0.120 |
Why?
|
| Stroke | 1 | 2016 | 9579 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 1230 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2016 | 405 | 0.110 |
Why?
|
| Thiamine | 1 | 2014 | 141 | 0.110 |
Why?
|
| Humans | 25 | 2023 | 725187 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1638 | 0.110 |
Why?
|
| Adaptation, Physiological | 3 | 2008 | 1329 | 0.110 |
Why?
|
| Axons | 1 | 2020 | 1688 | 0.110 |
Why?
|
| Social Behavior | 3 | 2010 | 1111 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 3965 | 0.110 |
Why?
|
| Narcotics | 3 | 2013 | 337 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 296 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2022 | 1262 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1823 | 0.100 |
Why?
|
| Dopamine | 3 | 2007 | 1607 | 0.100 |
Why?
|
| Serum Response Factor | 1 | 2010 | 98 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2023 | 12080 | 0.090 |
Why?
|
| H-2 Antigens | 1 | 2010 | 366 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2020 | 2909 | 0.090 |
Why?
|
| Morphine | 3 | 2013 | 648 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2150 | 0.090 |
Why?
|
| Rats | 9 | 2023 | 24414 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 7814 | 0.090 |
Why?
|
| Dominance-Subordination | 4 | 2010 | 28 | 0.090 |
Why?
|
| Antidepressive Agents | 4 | 2010 | 2750 | 0.090 |
Why?
|
| Veterans | 1 | 2022 | 2346 | 0.090 |
Why?
|
| Extremities | 1 | 2014 | 857 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2008 | 114 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 3 | 2009 | 5934 | 0.080 |
Why?
|
| Conditioning, Operant | 2 | 2006 | 316 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2008 | 135 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2008 | 4938 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 11968 | 0.080 |
Why?
|
| Emotions | 2 | 2010 | 2569 | 0.080 |
Why?
|
| Alleles | 1 | 2018 | 6952 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 775 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2009 | 428 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2013 | 23448 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2010 | 3024 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 513 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 478 | 0.070 |
Why?
|
| Motor Activity | 4 | 2010 | 2712 | 0.070 |
Why?
|
| Acute Disease | 1 | 2016 | 7095 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 673 | 0.070 |
Why?
|
| Social Environment | 1 | 2010 | 1008 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2006 | 327 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2008 | 1313 | 0.060 |
Why?
|
| Rats, Long-Evans | 3 | 2010 | 390 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7840 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2008 | 1002 | 0.060 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 607 | 0.060 |
Why?
|
| Benzamides | 1 | 2009 | 1372 | 0.060 |
Why?
|
| Limbic System | 1 | 2006 | 423 | 0.060 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 3822 | 0.060 |
Why?
|
| Receptors, Opioid | 1 | 2023 | 154 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2010 | 13044 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2023 | 14769 | 0.060 |
Why?
|
| Behavior, Addictive | 1 | 2008 | 449 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2023 | 177 | 0.050 |
Why?
|
| Protein Transport | 1 | 2008 | 2015 | 0.050 |
Why?
|
| Male | 21 | 2019 | 347096 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4799 | 0.050 |
Why?
|
| Macaca | 1 | 2023 | 450 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1406 | 0.050 |
Why?
|
| Methylation | 3 | 2010 | 1112 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9789 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 9964 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2002 | 358 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12935 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 2007 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2549 | 0.050 |
Why?
|
| Transgenes | 1 | 2023 | 1016 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2010 | 8361 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2008 | 1526 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 2005 | 1204 | 0.040 |
Why?
|
| Benzhydryl Compounds | 1 | 2005 | 767 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15420 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2005 | 929 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4234 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 900 | 0.040 |
Why?
|
| Synapses | 2 | 2023 | 1721 | 0.040 |
Why?
|
| Peptides | 1 | 2010 | 4390 | 0.040 |
Why?
|
| Self Administration | 2 | 2010 | 387 | 0.040 |
Why?
|
| Wakefulness | 1 | 2005 | 1231 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2943 | 0.040 |
Why?
|
| Pyridines | 1 | 2009 | 2807 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 29672 | 0.040 |
Why?
|
| Neostriatum | 2 | 2008 | 250 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2010 | 9022 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 1126 | 0.040 |
Why?
|
| Computational Biology | 1 | 2009 | 3526 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 922 | 0.030 |
Why?
|
| Ventral Tegmental Area | 2 | 2007 | 144 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2023 | 8487 | 0.030 |
Why?
|
| Social Isolation | 2 | 2009 | 355 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 10971 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2008 | 4011 | 0.030 |
Why?
|
| Fluoxetine | 2 | 2009 | 731 | 0.030 |
Why?
|
| Hippocampus | 1 | 2006 | 3604 | 0.030 |
Why?
|
| Sirtuin 2 | 1 | 2013 | 114 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2008 | 1992 | 0.030 |
Why?
|
| DNA Damage | 1 | 2002 | 2466 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2008 | 11484 | 0.030 |
Why?
|
| Mice, Inbred AKR | 1 | 2010 | 109 | 0.020 |
Why?
|
| Helplessness, Learned | 1 | 2010 | 28 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1821 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3467 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 5236 | 0.020 |
Why?
|
| Enzyme Repression | 1 | 2010 | 35 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 258 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6398 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2009 | 126 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2009 | 75 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2010 | 992 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 155 | 0.020 |
Why?
|
| Sucrose | 1 | 2009 | 171 | 0.020 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 36 | 0.020 |
Why?
|
| United States | 1 | 2016 | 68403 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5913 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2007 | 6436 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 166 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 461 | 0.020 |
Why?
|
| Female | 4 | 2023 | 375449 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 2008 | 166 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 134 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2009 | 286 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 34776 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 496 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 2359 | 0.020 |
Why?
|
| Food Preferences | 1 | 2009 | 391 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2938 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 84401 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3692 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 161486 | 0.020 |
Why?
|
| Gene Expression | 2 | 2009 | 7819 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1717 | 0.020 |
Why?
|
| DNA | 1 | 2019 | 7241 | 0.020 |
Why?
|
| Hallucinogens | 1 | 2008 | 160 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2005 | 113 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 1005 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 1121 | 0.020 |
Why?
|
| Butyrates | 1 | 2005 | 163 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 668 | 0.020 |
Why?
|
| Cell Size | 1 | 2006 | 645 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 569 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1476 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15442 | 0.020 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2002 | 72 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19485 | 0.010 |
Why?
|
| Narcolepsy | 1 | 2005 | 192 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 1404 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 978 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2002 | 262 | 0.010 |
Why?
|
| Ethanol | 1 | 2008 | 1293 | 0.010 |
Why?
|
| Models, Biological | 2 | 2009 | 9669 | 0.010 |
Why?
|
| Sleep, REM | 1 | 2005 | 583 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 432 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 927 | 0.010 |
Why?
|
| Aggression | 1 | 2006 | 741 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1448 | 0.010 |
Why?
|
| Time Factors | 3 | 2008 | 40186 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1242 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 1490 | 0.010 |
Why?
|
| Environment | 1 | 2005 | 1113 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 12991 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 1565 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13932 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2477 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 18301 | 0.010 |
Why?
|
| Genome | 1 | 2005 | 1801 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4350 | 0.010 |
Why?
|
| Anxiety | 1 | 2010 | 4079 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 3165 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 3902 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5460 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6371 | 0.010 |
Why?
|
| Attention | 1 | 2005 | 2388 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 74206 | 0.010 |
Why?
|
| DNA Repair | 1 | 2002 | 2047 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5914 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 2877 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9756 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 12902 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2005 | 6010 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 28145 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9716 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 212292 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 211615 | 0.000 |
Why?
|